Daniel Chamié, MD, PhD

Daniel Chamié is an Interventional Cardiologist with expertise in complex percutaneous coronary interventions (PCI), intravascular imaging modalities, and coronary physiology.

He received his M.D. degree in 2001 and completed his Internal Medicine and Cardiology residencies in Rio de Janeiro, Brazil, before moving to Sao Paulo, Brazil, where he completed the Hemodynamics and Interventional Cardiology training at Instituto Dante Pazzanese de Cardiologia, from 2006 and 2009. Between 2010 and 2012 he completed a 2-year research fellowship in Intravascular Imaging at the University Hospitals Case Medical Center, Case Western Reserve University in Cleveland, OH, where he advanced his knowledge in the use of intracoronary physiology and imaging, particularly optical coherence tomography (OCT).

Upon completing his research fellowship in Cleveland, Dr. Chamié returned to Brazil and served as faculty of the Interventional Cardiology Department at Instituto Dante Pazzanese de Cardiologia in Sao Paulo, where he practiced for 10 years expanding his skills in complex percutaneous coronary interventions and in the clinical use of intravascular imaging and physiology.

In 2019, he obtained his Ph.D. in Medicine, Technology, and Interventions in Cardiology from the University of Sao Paulo.

In parallel with his clinical activities, Dr. Chamié directed the OCT core laboratory at the Cardiovascular Research Center, Sao Paulo, Brazil,  from 2012 to 2020. During this time, he developed OCT analysis methods for several studies on novel devices (e.g. bioresorbable scaffolds, drug-eluting stents, specialty balloons) in various clinical scenarios (e.g. stable CAD, ACS, bifurcation lesions, high-bleeding risk patients, etc).

Over the last decade, he participated as an investigator for several clinical trials, first-in-man studies, registries, and observational studies. Dr. Chamié is the leading investigator of the iSIGHT trial and the VIP-LMS study. The former proposes an algorithmic approach for the use of intravascular imaging to guide PCI; the latter aims to validate the use of intracoronary physiology (iFR and FFR) and imaging (IVUS and OCT) in patients with intermediate left main coronary artery stenosis with concomitant severe downstream lesions.

In August 2022, Dr. Chamié moved to the US to join the Section of Cardiovascular Medicine at Yale School of Medicine in New Haven, CT as an Instructor. Over this period, he established intravascular ultrasound, optical coherence tomography, and coronary physiology core laboratories and is working in close collaboration with the cardiac catheterization laboratory team at Yale New Haven Health to advance the use of intravascular imaging modalities in clinical practice.

Dr. Chamié is a Commissioner for the Lancet Commission for Ischemic Heart Disease, working with a large group of leaders in the field to produce a forward-looking document that aims to advocate for increased awareness of the impact of atherosclerotic cardiovascular disease, to impact on health policy interventions targeted at prevention, early detection, and treatment of atherosclerotic heart disease globally, and to propose an agenda for atherosclerotic heart disease research for the next 20 years.

Dr. Chamié serves as an associate editor for the Journal of Transcatheter Interventions since 2018 and is a member of the editorial board of the JSCAI: Journal of the Society for Cardiovascular Angiography and Interventions since 2022. He is also a reviewer for high-impact peer-reviewed journals in the area of cardiovascular interventions (e.g. JACC Cardiovascular Interventions, Circulation: Cardiovascular Interventions, EuroIntervention, Cardiovascular Revascularization Medicine, and JSCAI) and is regularly invited to speak at leading international conferences.